SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-15-006040
Filing Date
2015-02-03
Accepted
2015-02-02 18:14:43
Documents
1
Group Members
ALAN R. SCHUELEDAVID J. MCLEANJACKIE R. KIMZEYJOHN T. OXAALJOHN V. JAGGERSNICHOLAS G. STURIALESEVIN ROSEN BAYLESS MANAGEMENT COSEVIN ROSEN FUND IX L.P.SEVIN ROSEN IX AFFILIATES FUND L.P.SRB ASSOCIATES IX L.P.STEPHEN L. DOMENIKSTEPHEN M. DOW

Document Format Files

Seq Description Document Type Size
1 BENEFICIAL OWNERSHIP OF 5% OR MORE a15-3578_1sc13g.htm SC 13G 331536
  Complete submission text file 0001104659-15-006040.txt   333289
Mailing Address C/O SEVIN ROSEN FUNDS 13455 NOEL RD #1670 DALLAS TX 75240
Business Address
BAYLESS JON W (Filed by) CIK: 0001026496 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Subject) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88142 | Film No.: 15568654
SIC: 2834 Pharmaceutical Preparations